Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

S&P Industrial Sector Intl SPDR (IPN)

S&P Industrial Sector Intl SPDR (IPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family N/A
  • Assets Under Management 0
  • Shares Outstanding, K 500
  • 60-Month Beta 0.96
Trade IPN with:
  • Price/Earnings ttm N/A
  • Annual Dividend & Yield 0.58 (1.66%)
  • Most Recent Dividend N/A on N/A
  • Management Fee N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.13 +1.70%
on 07/06/17
35.31 -1.70%
on 07/13/17
-0.11 (-0.32%)
since 06/23/17
3-Month
33.44 +3.80%
on 04/26/17
35.38 -1.89%
on 06/14/17
+1.38 (+4.14%)
since 04/24/17
52-Week
28.70 +20.94%
on 07/25/16
35.38 -1.89%
on 06/14/17
+6.02 (+20.98%)
since 07/22/16

Most Recent Stories

More News
Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen Delivers Strong Sales Growth in the First Nine Months of 2022 and Confirms Its Full-year Guidance

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen Statement on Updated Timeline for Palovarotene FDA Advisory Committee Meeting

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen Extends Expiration Date of Tender Offer for Epizyme, Inc. to 11 August 2022

Regulatory News:

OTC.VN : 0.400 (unch)
EPZM : 1.4700 (-1.34%)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates From Marengo’s STAR Platform Into the Clinic

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen Delivers Strong H1 2022 Results and Upgrades Its Full-Year Guidance

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen Announces U.S. FDA Priority Review for palovarotene New Drug Application in Patients With Fibrodysplasia Ossificans Progressiva Following Resubmission

Regulatory News:

OTC.VN : 0.400 (unch)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)
Ipsen to Acquire Epizyme, Expanding Its Portfolio in Oncology

Regulatory News:

OTC.VN : 0.400 (unch)
EPZM : 1.4700 (-1.34%)
IPN : 34.71 (-0.54%)
IPSEY : 28.9300 (+3.10%)

Fund Summary

N/A

See More

Top 10 Holdings

Name % Holdings

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 34.84
1st Resistance Point 34.77
Last Price 34.71
1st Support Level 34.58
2nd Support Level 34.46
3rd Support Level N/A

See More

52-Week High 35.38
Last Price 34.71
Fibonacci 61.8% 32.83
Fibonacci 50% 32.04
Fibonacci 38.2% 31.25
52-Week Low 28.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar